Revati Shreeniwas is a physician executive with 20 years of experience leading clinical development with extensive oncology, orphan disease, pharmacovigilance expertise. She led compound development teams and executed on development plans for a range of therapeutics (Phase 1-4) in respiratory, dermatology, infectious disease, neurology, and neuropsychiatry indications. She also has expertise in medical affairs spanning due diligence, KOL engagement, M&A (sell and buy) and medical marketing strategy. She has led the success launch and label extension of numerous commercial drugs. Revati is a highly published executive with over a dozen publications. She has developed thought leader engagement plans and advisory boards for development and medical affairs.